about
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC).Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors.Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.Lung cancer in women: an overview with special focus on Spanish women.Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel.Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study.Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.Bilateral choroidal metastases revealing an advanced non-small cell lung cancer.Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS).Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepamBone marrow examination in small cell lung cancer--when is it indicated?Prognostic impact of bulky mediastinal lymph nodes (N2>2.5 cm) in patients with locally advanced non-small-cell lung cancer (LA-NSCLC) treated with platinum-based induction chemotherapyCisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary
P50
Q27851712-74DAEEA0-6913-43C5-B972-9D20ECAF1562Q33327893-B1FE6E17-86A0-4DBA-83F9-67BD909FF2EBQ33339225-5F1F58E6-9966-4108-917C-426F8DF9A8CBQ33349736-13CA800D-C70A-46AB-9AB6-4FD0B55F71F9Q33364765-D54A9AB5-E699-4F7E-BB2D-F6269C6DC742Q38166318-CAA59CFE-8CB1-46CF-A00E-01D5BD87DF38Q38252486-2E41901E-F0D3-447F-9E81-03E816C694DEQ38999348-296FE6DF-109C-4687-97E9-179E6A612CF9Q43288716-0CC9F914-AA1B-40E9-9605-CFC244B0D8CFQ44311963-2D7030A0-B1F3-49C4-A570-4A055499918EQ44772615-5C5DB4CA-0DE3-41F2-AACD-F7E2B6FBCFA3Q44995386-4C890F4E-14CB-4D0F-B988-FDD65BA94573Q46942076-E148BA1C-01FB-45E7-B923-DC19F6FB4274Q48478240-2A33EE75-7576-46A4-9BF8-7B87C3B05440Q48666483-F407FE4A-AD16-466F-9835-EAB406E87B02Q67974004-F81425B5-7D8A-41D3-9C19-6BB581824623Q68253840-7C1A59B3-4BA1-45BC-B687-9463060958E1Q73209595-B2EE7270-1A0D-466B-B7C1-09A970F1D17DQ85995795-853BED72-088B-441A-988B-3230B2637CB5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Angel Artal
@ast
Angel Artal
@en
Angel Artal
@es
Angel Artal
@nl
type
label
Angel Artal
@ast
Angel Artal
@en
Angel Artal
@es
Angel Artal
@nl
prefLabel
Angel Artal
@ast
Angel Artal
@en
Angel Artal
@es
Angel Artal
@nl
P106
P21
P31
P496
0000-0002-9778-706X